DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PWT-33579
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-alpha subunit inhibitor
PWT-33579
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DV-281
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
DV-281
×
Maximum Phase:
1
First Approval:
None
UNII:
4LOR72V17G
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FARALIMOMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Interferon alpha-1/13 binding agent
FARALIMOMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIGAPOTIDE TRIFLUTATE
1
Protein
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
TIGAPOTIDE TRIFLUTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
6227JFW01C
Molecule Type:
Protein
Molecular Formula:
C84H120F3N21O36S3
Molecular Weight:
2153.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LYMPHOCYTE ACTIVATION GENE 3 PROTEIN
1
Unknown
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
LYMPHOCYTE ACTIVATION GENE 3 PROTEIN
×
Maximum Phase:
1
First Approval:
None
UNII:
AK0JDV1ZK5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
LY3185643
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3185643
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORT 108297
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Glucocorticoid receptor antagonist
CORT 108297
×
Maximum Phase:
1
First Approval:
None
UNII:
A17W0640NB
Molecule Type:
Small molecule
Molecular Formula:
C26H25F4N3O3S
Molecular Weight:
535.56
AlogP:
5.09
PSA:
64.43
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
EMFILERMIN
1
Protein
Investigational
Unknown
Unknown
Infertility
Unknown
EMFILERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
N70J8Y06YN
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KBP5209
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor inhibitor
KBP5209
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ENADENOTUCIREV
1
Unknown
Investigational
Unknown
Unknown
Ovarian Neoplasms; Rectal Neoplasms
Unknown
ENADENOTUCIREV
×
Maximum Phase:
1
First Approval:
None
UNII:
KX7ZYR6OQW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COM-701
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
COM-701
×
Maximum Phase:
1
First Approval:
None
UNII:
IAY02XUV7L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTULISM ANTITOXIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOTULISM ANTITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DWN-12088
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis
Unknown
DWN-12088
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H19Cl2N3O
Molecular Weight:
328.24
AlogP:
3.24
PSA:
50.08
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FS-102
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
FS-102
×
Maximum Phase:
1
First Approval:
None
UNII:
Z27ZI1MZY9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BPI-9016
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Hepatocyte growth factor receptor inhibitor
BPI-9016
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GACYCLIDINE
1
Small molecule
Investigational
Unknown
Unknown
Tinnitus
Unknown
GACYCLIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9290ND070R
Molecule Type:
Small molecule
Molecular Formula:
C16H25NS
Molecular Weight:
263.45
AlogP:
4.64
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
NV-5138
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Treatment-Resistant
Unknown
NV-5138
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C7H13F2NO2
Molecular Weight:
181.18
AlogP:
1.08
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
HM-71224
1
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
HM-71224
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986251
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986251
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C30H29F8NO5S
Molecular Weight:
667.61
AlogP:
6.47
PSA:
91.75
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ZAMPILIMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ZAMPILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
52B38H09GZ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MHAB5553A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MHAB5553A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ILS-920
1
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
ILS-920
×
Maximum Phase:
1
First Approval:
None
UNII:
F2D5P81X82
Molecule Type:
Small molecule
Molecular Formula:
C58H88N2O14
Molecular Weight:
1037.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SALCAPROZATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
SALCAPROZATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
1YTW0422YU
Molecule Type:
Small molecule
Molecular Formula:
C15H20NNaO4
Molecular Weight:
301.32
AlogP:
2.55
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
9.0
Source:
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
78
79
80
81
82
83
84
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA